# Convalescent Plasma vs. Standard Plasma for COVID-19

> **NCT04344535** · PHASE1,PHASE2 · TERMINATED · sponsor: **Stony Brook University** · enrollment: 82 (actual)

## Conditions studied

- COVID

## Interventions

- **BIOLOGICAL:** Convalescent Plasma
- **BIOLOGICAL:** Standard Donor Plasma

## Key facts

- **NCT ID:** NCT04344535
- **Lead sponsor:** Stony Brook University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-04-08
- **Primary completion:** 2021-01-01
- **Final completion:** 2021-02-01
- **Target enrollment:** 82 (ACTUAL)
- **Why stopped:** Insufficient eligible and consenting patients
- **Last updated:** 2021-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04344535

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04344535, "Convalescent Plasma vs. Standard Plasma for COVID-19". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04344535. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*